Abraxis BioScience Founder Awarded Ellis Island Medal of Honor
14 Maio 2007 - 5:05PM
Business Wire
Abraxis BioScience, Inc. (NASDAQ: ABBI), an integrated, global
biopharmaceutical company, today announced that Patrick
Soon-Shiong, M.D., founder, chairman of the board and chief
executive officer of the company, was among this year�s 100
recipients of the prestigious Ellis Island Medal of Honor. Honorees
this year included Her Excellency Sheikha Haya Rashed Al Khalifa
(President � General Assembly, United Nations), Denis A. Cortese,
M.D. (President and Chief Executive Officer - Mayo Clinic), Hon.
Chuck Hagel (U. S. Senator), Rep. Tom Lantos ((U.S. Congressman)
and Antonio M. Perez (Chairman and Chief Executive Officer -
Eastman Kodak Company). The award presentation took place at Ellis
Island on May 12, 2007 and the ceremony concluded with a fireworks
display at the Statue of Liberty. Dr. Soon-Shiong, who is of
Chinese heritage and a native of South Africa, is a noted research
scientist, physician and surgeon, and was awarded this honor for
his efforts in scientific innovation. He has devoted his career to
developing next-generation technologies to enhance the medical care
of patients with life-threatening diseases, including cancer,
diabetes and heart disease. Dr. Soon-Shiong performed the world�s
first encapsulated islet transplant in a diabetic patient,
developed the nanoparticle albumin bound (nab�) technology
platform, is a co-inventor of over 50 issued U.S. and foreign
patents and has published more than 100 scientific papers. As part
of his commitment to bringing about evolutionary change to the
practice of medicine and addressing the serious health care issues
facing the country, Dr. Soon-Shiong and his family recently donated
$35 million to the Saint John�s Health Center. The donation was
designed to complete the building of a world class inpatient life
science center, and to begin development of a new Center for
Translational Sciences. The Ellis Island Medal of Honor, sponsored
by the National Ethnic Coalition of Organizations, is presented
annually to Americans who have maintained strong ties to their
ancestry and furthered the growth of ethnic America. Previous
honorees have been outstanding Americans who have worked in
government, healthcare, industry, education, sports and
entertainment. Recipients have included six United States
Presidents, General Norman Schwarzkopf, Rudy Guiliani, Jay Leno,
Yogi Berra, Muhammad Ali and Walter Cronkite. About The Ellis
Island Medal of Honor Established in 1986 by NECO, the Ellis Island
Medals of Honor pay tribute to the ancestry groups that comprise
America's unique cultural mosaic. Held each May on Ellis Island,
the event is full of pageantry, grandeur and emotion. Both Houses
of Congress officially recognize the Medal of Honor, which ranks
among the nation's most prestigious awards. Past Medalists include
Supreme Court justices, Nobel Prize winners, American Presidents,
famous athletes, entertainers, corporate giants and individuals who
have inspired people, improved communities and changed lives for
the better. One is presented each year to a foreign citizen for
extraordinary service to the United States and the international
community. For a full list of the 2007 Ellis Island Medal of Honor
winners, visit www.neco.org. About NECO The National Ethnic
Coalition of Organizations, Inc. serves as an umbrella for over 250
organizations that celebrate, educate and nurture ethnic pride,
heritage, culture, tradition and commerce. NECO was created on the
conviction of its founders that the diversity of the American
people is what makes this nation great. Its mission is to honor and
preserve this diversity and to foster tolerance, respect and
understanding among religious and ethnic groups. About Abraxis
BioScience, Inc. Abraxis BioScience, Inc. is an integrated global
biopharmaceutical company dedicated to meeting the needs of
critically ill patients. The company�develops, manufactures and
markets one of the broadest portfolios of�injectable products and
leverages revolutionary technology such as its nab� platform
to�discover and deliver breakthrough therapeutics that transform
the treatment of cancer and other life-threatening diseases. The
first FDA approved product to use this nab platform, ABRAXANE�, was
launched in 2005 for the treatment of metastatic breast cancer.
Abraxis trades on the Nasdaq Global Market under the symbol ABBI.
For more information about the company and its products, please
visit www.abraxisbio.com.
Abraxis Bioscience (MM) (NASDAQ:ABBI)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Abraxis Bioscience (MM) (NASDAQ:ABBI)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024